A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide - Mumoli L, Ciriaco M, Gambardella A, Bombardiere GN, Valentino P, Palleria C, Labate A, Russo E.

β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affec...
Source: SafetyLit: All (Unduplicated) - Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news